American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update
- PMID: 15260010
American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update
Erratum in
- Endocr Pract. 2008 Sep;14(6):802-3. Petak, Steven M [added]; Nankin, Howard R [added]; Spark, Richard F [added]; Swerdloff, Ronald S [added]; Rodriguez-Rigau, Luis J [added]
Abstract
In these clinical practice guidelines, specific recommendations are made for determining the most effective methods of diagnosing and treating hypogonadism in adult male patients. The target populations for these guidelines include the following: (1) men with primary testicular failure requiring testosterone replacement (hypergonadotropic hypogonadism); (2) male patients with gonadotropin deficiency or dysfunction who may have received testosterone replacement therapy or treatment for infertility (hypogonadotropic hypogonadism); and (3) aging men with symptoms relating to testosterone deficiency who could benefit from testosterone replacement therapy. Initial hormonal evaluation generally consists of a testosterone determination, in conjunction with a free testosterone or sex hormone-binding globulin level, inpatients with clear symptoms and signs but normal-range total testosterone, follicle-stimulating hormone, luteinizing hormone, and prolactin levels. Other possible tests include semen analysis, pituitary imaging studies, genetic studies, bone densitometry, testicular ultrasonography,testicular biopsy, and specialized hormonal dynamic testing. Therapeutic options generally consist of testosterone replacement by injections, patches, or topically applied gel in hypergonadotropic patients and in hypogonadotropic patients not interested in fertility. In hypogonadotropic patients interested in fertility, gonadal stimulation option scan be considered, including human chorionic gonadotropin stimulation therapy with or without human menopausal gonadotropin (or follicle-stimulating hormone) or gonadotropin-releasing hormone pump therapy. These therapies may be combined with assisted reproductive technologies such as in vitro fertilization with intracytoplasmic sperm injection, which may allow pregnancy to occur with very low numbers of sperm.
Similar articles
-
Hormonal therapy of male hypogonadism.Endocrinol Metab Clin North Am. 1994 Dec;23(4):857-75. Endocrinol Metab Clin North Am. 1994. PMID: 7705324 Review.
-
Feedback inhibition of gonadotropins by testosterone in men with hypogonadotropic hypogonadism: comparison to the intact pituitary-testicular axis in primary hypogonadism.J Androl. 2006 May-Jun;27(3):358-64. doi: 10.2164/jandrol.05140. Epub 2006 Feb 10. J Androl. 2006. PMID: 16474013
-
[A hormone assay as a therapeutic choice in male sterility].J Gynecol Obstet Biol Reprod (Paris). 1990;19(7):881-8. J Gynecol Obstet Biol Reprod (Paris). 1990. PMID: 2126018 French.
-
Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.J Pediatr Endocrinol Metab. 1998;11 Suppl 3:885-90. J Pediatr Endocrinol Metab. 1998. PMID: 10091162
-
[Hormonal evaluation in infertile men].Gynecol Obstet Fertil. 2008 May;36(5):551-6. doi: 10.1016/j.gyobfe.2008.03.006. Epub 2008 May 6. Gynecol Obstet Fertil. 2008. PMID: 18462981 Review. French.
Cited by
-
Male hypogonadism: Symptoms and treatment.J Adv Pharm Technol Res. 2010 Jul;1(3):297-301. doi: 10.4103/0110-5558.72420. J Adv Pharm Technol Res. 2010. PMID: 22247861 Free PMC article.
-
The effectiveness of zinc supplementation in men with isolated hypogonadotropic hypogonadism.Asian J Androl. 2017 May-Jun;19(3):280-285. doi: 10.4103/1008-682X.189621. Asian J Androl. 2017. PMID: 27768007 Free PMC article.
-
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.Oncotarget. 2017 Mar 14;8(11):18424-18434. doi: 10.18632/oncotarget.12906. Oncotarget. 2017. PMID: 27793023 Free PMC article.
-
Psychometric testing of two new patient-reported outcome instruments for the evaluation of treatment for hypogonadism.Int J Clin Pract. 2016 Jul;70(7):587-95. doi: 10.1111/ijcp.12828. Epub 2016 Jun 13. Int J Clin Pract. 2016. PMID: 27291501 Free PMC article. Clinical Trial.
-
Quantitative Analysis of the Seminal Plasma Proteome in Secondary Hypogonadism.J Clin Med. 2019 Dec 3;8(12):2128. doi: 10.3390/jcm8122128. J Clin Med. 2019. PMID: 31816910 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources